Shelbourne Developments denied to today that it has pulled out of the deal to buy the Lloyd's Building.
It also slammed claims that it pulled out for monetary reasons.
A spokesperson for the company said: “We have not pulled out and financing is not an issue. There are no negotiations currently but negotiations will resume once due diligence issues are clarified.”
It is understood that Shelbourne halted the deal over the possible presence of ASR also known as ‘concrete cancer'. But a Shelbourne spokesperson could not confirm whether this was the case.
The spokesperson added: “We are currently waiting for Arup's final report on these due diligence issues.”
